Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
J Intellect Disabil Res ; 64(11): 864-874, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32959450

ABSTRACT

BACKGROUND: Recently, there has been an increasing number of trials of medications for fragile X syndrome (FXS). In order to be adequately powered, trials have involved many centres around the world with relatively small numbers of participants recruited at each site. This study aims to understand the barriers to, and how best to facilitate participation in, medication trials in order to improve recruitment and the experience of participants with FXS. METHODS: A mixed methods design was used to collect both quantitative and qualitative data. Participants were invited to participate through the UK Fragile X Society, a local mailing list and through social media. Those who agreed to participate completed a quantitative questionnaire and indicated whether they would be willing to participate in a follow-up focus group. RESULTS: The questionnaire was completed by 328 individuals who either had FXS, or were a parent, carer or family member of an individual with FXS. Over two-thirds of participants reported concern about side effects, while over one-third mentioned swallowing tablets, blood tests, financial aspects and travel as barriers to participation. Focus groups with 12 individuals highlighted themes of trial challenges, strategies to overcome these and motivating factors to participate. CONCLUSIONS: Many of the factors, which potentially negatively influence participation in a clinical trial for FXS, could be mitigated in relatively simple ways. Easily accessible information, particularly about safety issues, the research team and the trial environment should be standard practice. Desensitisation programmes for blood testing, provision of different preparations of medication (e.g. liquid) and use of a combination of local, remote and site visits to reduce travel and time should also be considered.

2.
J Autism Dev Disord ; 48(7): 2490-2505, 2018 07.
Article in English | MEDLINE | ID: mdl-29468576

ABSTRACT

Research on sex-related differences in Autism Spectrum Disorder (ASD) has been impeded by small samples. We pooled 28 datasets from 18 sites across nine European countries to examine sex differences in the ASD phenotype on the ADI-R (376 females, 1763 males) and ADOS (233 females, 1187 males). On the ADI-R, early childhood restricted and repetitive behaviours were lower in females than males, alongside comparable levels of social interaction and communication difficulties in females and males. Current ADI-R and ADOS scores showed no sex differences for ASD severity. There were lower socio-communicative symptoms in older compared to younger individuals. This large European ASD sample adds to the literature on sex and age variations of ASD symptomatology.


Subject(s)
Autism Spectrum Disorder/epidemiology , Adolescent , Adult , Age Factors , Autism Spectrum Disorder/diagnosis , Child , Child, Preschool , Female , Humans , Infant , Interpersonal Relations , Male , Phenotype , Sex Characteristics
3.
Mol Psychiatry ; 22(10): 1455-1463, 2017 10.
Article in English | MEDLINE | ID: mdl-27217146

ABSTRACT

Finding robust brain substrates of mood disorders is an important target for research. The degree to which major depression (MDD) and bipolar disorder (BD) are associated with common and/or distinct patterns of volumetric changes is nevertheless unclear. Furthermore, the extant literature is heterogeneous with respect to the nature of these changes. We report a meta-analysis of voxel-based morphometry (VBM) studies in MDD and BD. We identified studies published up to January 2015 that compared grey matter in MDD (50 data sets including 4101 individuals) and BD (36 data sets including 2407 individuals) using whole-brain VBM. We used statistical maps from the studies included where available and reported peak coordinates otherwise. Group comparisons and conjunction analyses identified regions in which the disorders showed common and distinct patterns of volumetric alteration. Both disorders were associated with lower grey-matter volume relative to healthy individuals in a number of areas. Conjunction analysis showed smaller volumes in both disorders in clusters in the dorsomedial and ventromedial prefrontal cortex, including the anterior cingulate cortex and bilateral insula. Group comparisons indicated that findings of smaller grey-matter volumes relative to controls in the right dorsolateral prefrontal cortex and left hippocampus, along with cerebellar, temporal and parietal regions were more substantial in major depression. These results suggest that MDD and BD are characterised by both common and distinct patterns of grey-matter volume changes. This combination of differences and similarities has the potential to inform the development of diagnostic biomarkers for these conditions.


Subject(s)
Bipolar Disorder/physiopathology , Depressive Disorder, Major/physiopathology , Gray Matter/physiopathology , Adult , Bipolar Disorder/diagnostic imaging , Brain/physiopathology , Case-Control Studies , Depressive Disorder, Major/diagnostic imaging , Female , Gray Matter/anatomy & histology , Gray Matter/diagnostic imaging , Humans , Magnetic Resonance Imaging/methods , Male , Neuroimaging/methods , Prefrontal Cortex/physiopathology
4.
J Intellect Disabil Res ; 57(8): 766-33, 2013 Aug.
Article in English | MEDLINE | ID: mdl-22369675

ABSTRACT

BACKGROUND: This study investigates the role of IQ, autistic traits and challenging behaviours in affecting adult outcomes among adolescents who receive special educational assistance. METHODS: A total of 58 participants were recruited from an ongoing longitudinal study. All received assessments of IQ, behavioural patterns (using the Childhood Behaviour Checklist - CBCL) and autistic traits (using the Social Communication Questionnaire - SCQ) during adolescence and were followed up 6 years later (at a mean age of 22 years) using the World Health Organization Disability Assessment Schedule II (WHO-DAS II) to assess functional outcome. RESULTS: A significant positive relationship was found between CBCL score and WHO-DAS II score (ß = 0.511, P = 0.001). IQ score showed a negative relationship with total WHO-DAS II score (ß = -0.247, P = 0.04). SCQ score was not found to significantly influence total WHO-DAS II score (ß = -0.028, P = 0.84). CONCLUSIONS: Although the role of global intellectual ability is important, these results stress the highly predictive value of adolescent behaviours on functional outcomes in adult life among young adults receiving special educational assistance.


Subject(s)
Autism Spectrum Disorder/therapy , Education, Special , Intellectual Disability/therapy , Outcome Assessment, Health Care , Problem Behavior/psychology , Adolescent , Asperger Syndrome/diagnosis , Asperger Syndrome/psychology , Asperger Syndrome/therapy , Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/psychology , Attention Deficit Disorder with Hyperactivity/therapy , Autism Spectrum Disorder/diagnosis , Autism Spectrum Disorder/psychology , Checklist , Comorbidity , Dyslexia/diagnosis , Dyslexia/psychology , Dyslexia/therapy , Female , Humans , Intellectual Disability/diagnosis , Intellectual Disability/psychology , Longitudinal Studies , Male , Scotland , Surveys and Questionnaires , Young Adult
5.
Eur Psychiatry ; 27(5): 377-85, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22512930

ABSTRACT

BACKGROUND: Morphological abnormalities of the anterior cingulate (AC) occur in patients with schizophrenia and in symptomatic high-risk individuals, and may be predictive of subsequent psychosis. We investigated AC sulcal morphology in the Edinburgh High Risk Study cohort to see if such abnormalities are evident and predict psychosis in patients' relatives. We also investigated the association of the cingulate sulcus (CS) and paracingulate sulcus (PCS) variants with intelligence quotient (IQ). PATIENTS AND METHODS: We compared cingulate and paracingulate sulcal anatomy, using reliable standardised measurements, blind to group membership, in those at high genetic risk (n=146), first episode patients (n=34) and healthy controls (n=36); and compared high-risk subjects who did (n=17) or did not develop schizophrenia. RESULTS: Interruptions of the cingulate sulcus were more common in high-risk individuals and in those with schizophrenia, in both hemispheres, compared to controls. When separated by gender, these results were only present in males in the left hemisphere and only in females in the right hemisphere. A well-formed paracingulate sulcus was less common in high-risk participants and patients with schizophrenia, compared to controls; but this association was only present in males. These morphological variants of the paracingulate sulcus and the continuous cingulate sulcus were also associated with the higher IQ in male high-risk individuals. CONCLUSIONS: An interrupted cingulate sulcus pattern in both males and females and paracingulate morphology in males are associated with increased genetic risk of schizophrenia. Associations between cingulate and paracingulate morphology and premorbid IQ scores provide evidence that intellectual ability could be related to particular cytoarchitectural brain regions. Given that these sulci develop in early fetal life, such findings presumably reflect early neurodevelopmental abnormalities of genetic origin, although environmental effects and interactions cannot be ruled out.


Subject(s)
Gyrus Cinguli/pathology , Schizophrenia/genetics , Schizophrenia/pathology , Adult , Female , Genetic Predisposition to Disease , Humans , Longitudinal Studies , Magnetic Resonance Imaging , Male , Organ Size , Prospective Studies
6.
Eur Psychiatry ; 25(6): 366-72, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20542665

ABSTRACT

BACKGROUND: Abnormalities of orbitofrontal cortex (OFC) sulcogyral patterns have been reported in schizophrenia, but it is not known if these predate psychosis. METHODS: Hundred and forty-six subjects at high genetic risk of schizophrenia, 34 first episode of schizophrenia patients (SZ) and 36 healthy controls were scanned and clinically assessed. Utilising the classification system proposed by Chiavaras, we categorised OFC patterns and compared their distribution between the groups, as well as between those high risk subjects who did, and did not develop schizophrenia. The relationship between OFC pattern and schizotypy was explored in high risk subjects. RESULTS: We refined Chiavaras' classification system, with the identification of a previously unreported variant of OFC surface structure. There were significant differences in distribution of OFC patterns between high risk subjects who did or did not develop schizophrenia as well as between the first episode of schizophrenia group and healthy controls. Within the high risk group, possession of OFC Type III was associated with higher ratings on the Structured Inventory for Schizotypy (SIS) psychotic factor. CONCLUSIONS: Our results suggest that OFC Type III is associated with psychotic features before the development of schizophrenia. Characterisation of OFC morphology may have a role in the identification of those at greatest risk of developing schizophrenia.


Subject(s)
Frontal Lobe/pathology , Magnetic Resonance Imaging , Schizophrenia/pathology , Schizophrenic Psychology , Social Behavior , Adolescent , Adult , Case-Control Studies , Female , Follow-Up Studies , Humans , Male , Psychiatric Status Rating Scales , Risk Factors , Schizophrenia/classification , Schizophrenia/diagnosis , Young Adult
7.
Psychol Med ; 40(11): 1919-29, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20102666

ABSTRACT

BACKGROUND: Previous behavioural and neuroimaging studies of emotion processing in autistic spectrum disorder (ASD) have focused on the use of facial stimuli. To date, however, no studies have examined emotion processing in autism across a broad range of social signals. METHOD: This study addressed this issue by investigating emotion processing in a group of 23 adults with ASD and 23 age- and gender-matched controls. Recognition of basic emotions ('happiness', 'sadness', 'anger', disgust' and 'fear') was assessed from facial, body movement and vocal stimuli. The ability to make social judgements (such as approachability) from facial stimuli was also investigated. RESULTS: Significant deficits in emotion recognition were found in the ASD group relative to the control group across all stimulus domains (faces, body movements and voices). These deficits were seen across a range of emotions. The ASD group were also impaired in making social judgements compared to the control group and this correlated with impairments in basic emotion recognition. CONCLUSIONS: This study demonstrates that there are significant and broad-ranging deficits in emotion processing in ASD present across a range of stimulus domains and in the auditory and visual modality; they cannot therefore be accounted for simply in terms of impairments in face processing or in the visual modality alone. These results identify a core deficit affecting the processing of a wide range of emotional information in ASD, which contributes to the impairments in social function seen in people with this condition.


Subject(s)
Child Development Disorders, Pervasive/psychology , Emotional Intelligence , Adult , Case-Control Studies , Child , Child Development Disorders, Pervasive/physiopathology , Cognition , Emotions , Facial Expression , Female , Humans , Interpersonal Relations , Judgment , Male , Movement , Speech , Wechsler Scales
8.
Psychol Med ; 40(6): 945-54, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19732477

ABSTRACT

BACKGROUND: The mildly learning disabled population has a three-fold elevated risk for schizophrenia. It has been proposed that in some individuals this cognitive limitation is a pre-psychotic manifestation of early onset schizophrenia. We examined clinical and neuroanatomical measures of a putative extended phenotype of schizophrenia in an adolescent population receiving special educational assistance. We predicted that people with intellectual impairment and schizotypal features would exhibit amygdala volume reduction as one of the neuroanatomical abnormalities associated with schizophrenia. METHOD: Assessment by clinical interview, neuropsychological assessment and magnetic resonance imaging scanning was carried out in 28 intellectually impaired individuals identified as being at elevated risk of schizophrenia due to the presence of schizotypal traits, 39 intellectually impaired controls and 29 non-intellectually impaired controls. Amygdala volume was compared in these three groups and the relationship between symptomatology and amygdala volume investigated. RESULTS: Right amygdala volume was significantly increased in the elevated risk group compared with the intellectually impaired controls (p=0.05). A significant negative correlation was seen between left amygdala volume and severity of negative symptoms within this group (p<0.05), but not in either control group. CONCLUSIONS: Intellectually impaired subjects judged to be at elevated risk of schizophrenia on the basis of clinical assessment exhibit structural imaging findings which distinguish them from the generality of learning disabled subjects. Within this population reduced amygdala volume may be associated with negative-type symptoms and be part of an extended phenotype that reflects particularly elevated risk and/or early manifestations of the development of psychosis.


Subject(s)
Amygdala/pathology , Education, Special , Image Processing, Computer-Assisted , Learning Disabilities/diagnosis , Magnetic Resonance Imaging , Schizophrenia/diagnosis , Schizophrenic Psychology , Schizotypal Personality Disorder/diagnosis , Adolescent , Analysis of Variance , Dominance, Cerebral/physiology , Female , Humans , Intellectual Disability/diagnosis , Intellectual Disability/pathology , Intellectual Disability/psychology , Intelligence/physiology , Interview, Psychological , Learning Disabilities/pathology , Learning Disabilities/psychology , Male , Neuropsychological Tests/statistics & numerical data , Organ Size/physiology , Phenotype , Psychiatric Status Rating Scales/statistics & numerical data , Psychometrics , Risk Factors , Schizophrenia/pathology , Schizotypal Personality Disorder/pathology , Schizotypal Personality Disorder/psychology , Sex Factors
9.
Acta Psychiatr Scand ; 119(3): 192-8, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19032702

ABSTRACT

OBJECTIVE: We sought to address whether dorsal or ventral prefrontal gyrification is abnormal in bipolar disorder and to determine its diagnostic specificity and cognitive associations. METHOD: Forty-two out-patients with bipolar disorder, 28 with schizophrenia and 37 controls underwent magnetic resonance imaging. All subjects also underwent IQ and executive assessments using tasks whose performance has been localized to the ventral or dorsal prefrontal cortex. Cortical folding was quantified using the gyrification index (GI) and related to the cognitive measures. RESULTS: Patients with bipolar disorder showed reduced prefrontal gyrification compared with controls but did not differ from patients with schizophrenia. Neither ventral nor dorsal GI was preferentially affected in either disorder. Current IQ was positively and significantly correlated with GI. CONCLUSION: Patients with bipolar disorder and patients with schizophrenia have reduced prefrontal gyrification affecting both ventral and dorsal subregions. These reductions were significantly associated with cognitive impairments occurring in both disorders.


Subject(s)
Bipolar Disorder/physiopathology , Cognition Disorders/physiopathology , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Prefrontal Cortex/abnormalities , Schizophrenia/physiopathology , Adult , Bipolar Disorder/diagnosis , Cognition Disorders/diagnosis , Dominance, Cerebral/physiology , Female , Humans , Intelligence/physiology , Male , Middle Aged , Neuropsychological Tests/statistics & numerical data , Prefrontal Cortex/pathology , Prefrontal Cortex/physiopathology , Psychiatric Status Rating Scales/statistics & numerical data , Psychometrics , Reference Values , Schizophrenia/diagnosis , Software
10.
J Affect Disord ; 109(1-2): 99-106, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18164074

ABSTRACT

BACKGROUND: Subjects at high risk of schizophrenia for genetic reasons were found to demonstrate increased levels of depressive symptoms compared to controls. The current study sought to investigate the neural correlates of depression in these subjects. We hypothesised abnormal activation of dorsolateral prefrontal regions in those at high risk with depression. METHODS: Depression was rated according to DSM-IV criteria. FMRI data was available from 90 high risk subjects, comprising 78 not depressed (HRD-) and 12 depressed (HRD+) subjects. Activation during the Hayling Sentence Completion Task was compared to 25 healthy control subjects without depression. RESULTS: The HRD+ group demonstrated reduced activation of the right middle/superior frontal gyrus compared to both healthy controls and the HRD- group. Increased left superior temporal gyrus activation was also found in the HRD+ group versus the HRD- group. These results survived controlling for the presence of positive psychotic symptoms at the time of the scan. CONCLUSION: Reduced activation of dorsolateral prefrontal regions, widely reported in established schizophrenia and seen here in people at high familial risk with depressive features, may be related to the presence of affective symptoms of the disorder rather than to the presence of positive psychotic symptoms. Since studies have indicated that depressive symptoms antecede illness, these findings may be relevant to the early features of developing psychosis.


Subject(s)
Depressive Disorder/epidemiology , Depressive Disorder/psychology , Frontal Lobe/physiopathology , Schizophrenia/epidemiology , Schizophrenia/physiopathology , Adolescent , Adult , Demography , Depressive Disorder/diagnosis , Diagnostic and Statistical Manual of Mental Disorders , Female , Functional Laterality/physiology , Humans , Magnetic Resonance Imaging , Male , Prevalence , Risk Factors
11.
Cochrane Database Syst Rev ; (3): CD003442, 2006 Jul 19.
Article in English | MEDLINE | ID: mdl-16856009

ABSTRACT

BACKGROUND: Schizophrenia is a severe mental illness characterised by delusions and hallucinations. Antipsychotic drugs does reduce these symptoms, but at least half of people given these drugs do not comply with the treatment regimen prescribed. OBJECTIVES: To assess the effects of compliance therapy on antipsychotic medication adherence for people with schizophrenia. SEARCH STRATEGY: Cochrane Schizophrenia Group Trials Register (June 2005). SELECTION CRITERIA: We included all randomised controlled trials of 'compliance therapy' for people with schizophrenia or related severe mental disorders. DATA COLLECTION AND ANALYSIS: We independently extracted data and, for dichotomous data, calculated the relative risk (RR), its 95% confidence interval (CI) on an intention to treat basis. We present continuous data using the weighted mean difference statistic. MAIN RESULTS: We included one trial with relevant and available data (n=56, duration 2 years) comparing compliance therapy with non-specific counseling. The primary outcome 'non-compliance with treatment' showed no significant difference between compliance therapy and non-specific counseling (n=56, RR 1.23 CI 0.74 to 2.05). The compliance therapy did not substantially effect attitudes to treatment (n=50, WMD DAI score -2.10 CI -6.11 to 1.91). Very few people (~10%) left the study by one year (n=56, RR 0.5 CI 0.1 to 2.51). Mental state seemed unaffected by the therapy (n=50, WMD PANSS score 6.1 CI -4.54 to 16.74) as was insight (n=50, WMD SAI -0.5 CI -2.43 to 1.43), global functioning (n=50, WMD GAF -4.20 CI -16.42 to 8.02) and quality of life (n=50, WMD QLS -3.40 CI -16.25 to 9.45). At both one and two years the average number of days in hospital was non-significantly reduced for those allocated to the compliance therapy. AUTHORS' CONCLUSIONS: There is no clear evidence to suggest that compliance therapy is beneficial for people with schizophrenia and related syndromes but more randomised studies are justified and needed in order for this intervention to be fully examined.


Subject(s)
Antipsychotic Agents/therapeutic use , Patient Compliance , Schizophrenia/drug therapy , Confidence Intervals , Humans , Recurrence , Risk
SELECTION OF CITATIONS
SEARCH DETAIL
...